These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17005381)

  • 1. Non-viral gene therapy for Duchenne muscular dystrophy: progress and challenges.
    Rando TA
    Biochim Biophys Acta; 2007 Feb; 1772(2):263-71. PubMed ID: 17005381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the use of gene therapy to treat Duchenne muscular dystrophy.
    Jarmin S; Kymalainen H; Popplewell L; Dickson G
    Expert Opin Biol Ther; 2014 Feb; 14(2):209-30. PubMed ID: 24308293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic therapeutic approaches for Duchenne muscular dystrophy.
    Foster H; Popplewell L; Dickson G
    Hum Gene Ther; 2012 Jul; 23(7):676-87. PubMed ID: 22647146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in China.
    Liu X; Liu M; Wu L; Liang D
    Hum Gene Ther; 2018 Feb; 29(2):146-150. PubMed ID: 29366352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular-targeted therapy for Duchenne muscular dystrophy: progress and potential.
    Scimè A; Rudnicki MA
    Mol Diagn Ther; 2008; 12(2):99-108. PubMed ID: 18422374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides.
    Bertoni C
    Front Biosci; 2008 Jan; 13():517-27. PubMed ID: 17981565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne muscular dystrophy: genome editing gives new hope for treatment.
    Crispi V; Matsakas A
    Postgrad Med J; 2018 May; 94(1111):296-304. PubMed ID: 29386334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon-skipping therapy for Duchenne muscular dystrophy.
    Nakamura A; Takeda S
    Neuropathology; 2009 Aug; 29(4):494-501. PubMed ID: 19486303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for Duchenne muscular dystrophy.
    Verhaart IE; Aartsma-Rus A
    Curr Opin Neurol; 2012 Oct; 25(5):588-96. PubMed ID: 22892952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in exon skipping and splice modulation therapies for neuromuscular diseases.
    Touznik A; Lee JJ; Yokota T
    Expert Opin Biol Ther; 2014 Jun; 14(6):809-19. PubMed ID: 24620745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy: an updated review of common available therapies.
    Salmaninejad A; Valilou SF; Bayat H; Ebadi N; Daraei A; Yousefi M; Nesaei A; Mojarrad M
    Int J Neurosci; 2018 Sep; 128(9):854-864. PubMed ID: 29351004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene correction of a duchenne muscular dystrophy mutation by meganuclease-enhanced exon knock-in.
    Popplewell L; Koo T; Leclerc X; Duclert A; Mamchaoui K; Gouble A; Mouly V; Voit T; Pâques F; Cédrone F; Isman O; Yáñez-Muñoz RJ; Dickson G
    Hum Gene Ther; 2013 Jul; 24(7):692-701. PubMed ID: 23790397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances of treatment for Duchenne muscular dystrophy with exon skipping].
    Yang J; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):406-8. PubMed ID: 21811980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vector-mediated gene therapies.
    Hollinger K; Chamberlain JS
    Curr Opin Neurol; 2015 Oct; 28(5):522-7. PubMed ID: 26263476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy.
    Himič V; Davies KE
    Eur J Hum Genet; 2021 Sep; 29(9):1369-1376. PubMed ID: 33564172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing intervention for Duchenne muscular dystrophy.
    McClorey G; Fletcher S; Wilton S
    Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the smallest virus to the biggest gene: marching towards gene therapy for duchenne muscular dystrophy.
    Duan D
    Discov Med; 2006 Jun; 6(33):103-8. PubMed ID: 17234143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic treatments in muscular dystrophies.
    Muntoni F; Wells D
    Curr Opin Neurol; 2007 Oct; 20(5):590-4. PubMed ID: 17885450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?
    Yokota T; Duddy W; Echigoya Y; Kolski H
    Expert Opin Biol Ther; 2012 Sep; 12(9):1141-52. PubMed ID: 22650324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
    Blankinship MJ; Gregorevic P; Chamberlain JS
    Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.